Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class ASSE: 688076

Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection

· Issued by Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment